Natco net declines 43% on lower revenue

June 17, 2021 10:52 pm | Updated 10:52 pm IST - HYDERABAD

Natco Pharma reported a 43% decline in consolidated net profit for Q4 to ₹53 crore on the back of lower revenue in the base business. Total income dropped 25% to ₹359.7 crore. For FY21, the net profit slid 3.4% to ₹442.4 crore, while total revenue rose 6.6% to ₹2,155.7 crore (₹2,022.4 crore). Natco Pharma said it was able to sustain revenue during the year despite significant negative impact of the pandemic on the base business. The company said strong growth is expected in the current fiscal due to multiple high value product launches in the U.S, rebound in domestic India business with new products and contribution from Crop Health division.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.